Your browser doesn't support javascript.
loading
European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer.
van Kalsbeek, Rebecca J; van der Pal, Helena J H; Kremer, Leontien C M; Bardi, Edit; Brown, Morven C; Effeney, Rachel; Winther, Jeanette F; Follin, Cecilia; den Hartogh, Jaap; Haupt, Riccardo; Hjorth, Lars; Kepak, Tomas; Kepakova, Katerina; Levitt, Gill; Loonen, Jacqueline J; Mangelschots, Marlies; Muraca, Monica; Renard, Marleen; Sabic, Harun; Schneider, Carina U; Uyttebroeck, Anne; Skinner, Roderick; Mulder, Renée L.
Afiliação
  • van Kalsbeek RJ; Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, Utrecht, 3584 CS, the Netherlands. Electronic address: R.J.vanKalsbeek@prinsesmaximacentrum.nl.
  • van der Pal HJH; Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, Utrecht, 3584 CS, the Netherlands; PanCare, Jacobus Bellamylaan 16, Bussum, 1401 AZ, the Netherlands.
  • Kremer LCM; Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, Utrecht, 3584 CS, the Netherlands; Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Meibergdreef 9, Amsterdam, 1105 AZ, the Netherlands; Faculty of Medicine, Utrecht University and Utrecht Medical Centre, Universit
  • Bardi E; PanCare, Jacobus Bellamylaan 16, Bussum, 1401 AZ, the Netherlands; St Anna Children's Hospital, Kinderspitalgasse 6, Vienna, 1090, Austria; Department of Paediatric and Adolescent Medicine, Kepler University Clinic, 26-30 Krankenhausstraße, Linz, 4020, Austria.
  • Brown MC; Population Health Sciences Institute, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK; Newcastle University Centre for Cancer, Wolfson Childhood Cancer Research Centre, Herschel Building, Brewery Lane, Newcastle upon T
  • Effeney R; European Society for Paediatric Oncology, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30, Brussels, BE-1200, Belgium.
  • Winther JF; European Society for Paediatric Oncology, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30, Brussels, BE-1200, Belgium; Childhood Cancer Research Group, Danish Cancer Society Research Centre, Strandboulevarden 49, Copenhagen, 2100, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhu
  • Follin C; Oncology, Department of Clinical Sciences Lund, Lund University, Skane University Hospital, Lasarettsgatan 40, Lund, 221 85, Sweden.
  • den Hartogh J; PanCare, Jacobus Bellamylaan 16, Bussum, 1401 AZ, the Netherlands; Childhood Cancer International - Europe, Servitengasse 5/16, Vienna, 1090, Austria.
  • Haupt R; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, Genoa, 16147, Italy.
  • Hjorth L; Paediatrics, Department of Clinical Sciences Lund, Lund University, Skane University Hospital, Lasarettsgatan 40, Lund, 221 85, Sweden.
  • Kepak T; International Clinical Research Center (FNUSA-ICRC) at St. Anne's University Hospital, Masaryk University, Pekarská 53, Brno, 656 91, Czech Republic.
  • Kepakova K; International Clinical Research Center (FNUSA-ICRC) at St. Anne's University Hospital, Masaryk University, Pekarská 53, Brno, 656 91, Czech Republic.
  • Levitt G; Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London, WC1N 3JH, UK.
  • Loonen JJ; Department of Hematology, Radboud Institute for Health Sciences, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen, 6525 GA, the Netherlands.
  • Mangelschots M; Department of Oncology, Paediatric Oncology, KU Leuven, Belgium.
  • Muraca M; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Via G. Gaslini 5, Genoa, 16147, Italy.
  • Renard M; Department of Oncology, Paediatric Oncology, KU Leuven, Belgium.
  • Sabic H; Childhood Cancer International - Europe, Servitengasse 5/16, Vienna, 1090, Austria.
  • Schneider CU; Childhood Cancer International - Europe, Servitengasse 5/16, Vienna, 1090, Austria.
  • Uyttebroeck A; Department of Oncology, Paediatric Oncology, KU Leuven, Belgium; Department of Paediatric Haematology and Oncology, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium.
  • Skinner R; Department of Paediatric and Adolescent Medicine, Kepler University Clinic, 26-30 Krankenhausstraße, Linz, 4020, Austria; Great North Children's Hospital, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4 LP, UK; Translational and Clinical Research Institute, Wolfson Childhoo
  • Mulder RL; Princess Máxima Centre for Paediatric Oncology, Heidelberglaan 25, Utrecht, 3584 CS, the Netherlands.
Eur J Cancer ; 154: 316-328, 2021 09.
Article em En | MEDLINE | ID: mdl-34333209

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline / Screening_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline / Screening_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article